Picture of Equillium logo

EQ Equillium Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Equillium, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-39.1-62.4-13.3-8.07-22.4
Depreciation
Non-Cash Items5.253.6-6.03-11.91.85
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital1.70.019-2.550.842-2.32
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-32.1-8.73-21.8-19-22.7
Capital Expenditures-0.057-0.279-0.05-0.085-0.048
Purchase of Fixed Assets
Other Investing Cash Flow Items27.519-4.7113.94.51
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities27.418.7-4.7613.84.46
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities31.1-1.22-9.230.16430.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash26.48.74-35.9-5.1312.2